Human Papillomavirus (HPV) Type Distribution in Adult African Women Diagnosed With Invasive Cervical Cancer
- A female aged 21 years or more, presenting with a lesion macroscopically suggestive
of invasive cervical cancer.
- Scheduled for cervical biopsy as per routine procedure at the participating
institution on the day of the visit or on a later date.
- Written or oral-witnessed informed consent obtained from the subject prior to any
- No prior chemo- or radiotherapy for cervical cancer.
Type of Study:
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Occurrence of any of the human papillomavirus types (HPV-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with invasive cervical cancer
Outcome Time Frame:
Average time frame: 6-12 months
GSK Clinical Trials
Nigeria: National Agency for Food and Drug Administration and Control (NAFDAC)
- Infections, Papillomavirus
- Cervical Cancer
- Human papillomavirus
- Uterine Cervical Neoplasms